id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-D-0029-0003,FDA,FDA-2000-D-0029,FDA,Notice,NAD-Notice of Availability of Data,2006-02-15T05:00:00Z,2006,2,2006-02-13T05:00:00Z,2007-02-14T04:59:59Z,2008-04-25T01:01:33Z,,0,0,09000064804aeb49
FDA-2000-D-0029-0002,FDA,FDA-2000-D-0029,"Considerations for Developmental Toxicity Studies for Preventive and
Therapeutic Vaccines for Infectious Disease Indications",Supporting & Related Material,Guidance,2006-02-15T05:00:00Z,2006,2,,,2020-05-13T18:23:26Z,,0,0,09000064804aeb48
FDA-2000-D-0029-0001,FDA,FDA-2000-D-0029,FDA,Notice,NAD-Notice of Availability of Data,2000-09-14T04:00:00Z,2000,9,2000-09-08T04:00:00Z,2000-12-08T04:59:59Z,2008-04-25T01:01:33Z,,0,0,09000064804aeb36